Auxilium Pharmaceuticals — Merger or Acquisition (October 2014)
15 slides from Auxilium Pharmaceuticals's merger presentation, Oct 15, 2014
Slide 1: Auxilium & Endo: A Compelling Combination
Auxilium & Endo: A Compelling Combination Rajiv De Silva October 15, 2014
Slide 2: Additional Information
ADDITIONAL INFORMATION This communication does not constitute an offer to buy or solicitation of an offer to sell any securities. This communication relates to a proposed business combination transaction between Endo International plc ("Endo") and Auxilium Pharmaceuticals, Inc. ("Auxilium"). In furt
Slide 3: Forward-Looking Statements
This communication may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of and Canadian securities legislation. These forward-looking statements include, but are not limited to, statements regarding the proposed transaction, the financing of the p
Slide 4: Who is Endo International plc?
Who is Endo International plc? Endo International plc is a global specialty healthcare company focused on improving patients’ lives while creating shareholder value. Endo develops, manufactures, markets, and distributes quality branded pharmaceutical, generic and device products through its operatin
Slide 5: Endo International plc Companies
Endo International plc Companies
Slide 6: Company History
©2014 Endo Pharmaceuticals Inc. All rights reserved. Company History
Slide 7: Endo's Vision and Key Values
TEAMWORK TEAMWORK Unite to deliver superior results Endo’s Vision and Key Values To become a leading global specialty healthcare company that improves lives while creating value CUSTOMER FOCUS CUSTOMER FOCUS Commit to creating value RESULTS DRIVEN RESULTS DRIVEN Perform to exceed expectations LEADER
Slide 8: Our Roadmap to Success
Our Roadmap to Success Be nimble and entrepreneurial Be the best manager of assets Deliver relevant products to market Be efficient acquirers and integrators of new businesses Stay a step ahead and outperform our competitors Embrace high performance standards Act in a compliant and ethical manner
Slide 9: Expanding Presence Globally
Expanding Presence Globally
Slide 10: Endo and Auxilium: A Compelling Combination
Endo and Auxilium: A Compelling Combination ©2014 Endo Pharmaceuticals Inc. All rights reserved. Creates value for patients, customers and shareholders Establishes a leading branded specialty pharmaceutical business with a focus in men's healthcare, pain and rare/orphan diseases Accelerates organic
Slide 11: Select Highlights of Complementary Product Portfolio
Men’s Health / Urology Orthopedics / Pain Other Specialty Select Highlights of Complementary Product Portfolio Men’s Health / Urology Orthopedics / Pain Other Specialty Testosterone Gel 1% Authorized Generic
Slide 12: What Does This Mean For Employees of Auxilium?
Bringing our two organizations together will require us to look for efficiencies in overlapping areas There will be some workforce reductions Commitment to transparency, fairness and speed in integration post-close True value of combination is in accelerating long-term growth potential Commitment to
Slide 13: Next Steps
We expect the close of this transaction to take place in first half of 2015, subject to: Regulatory approval in the U.S. Auxilium stockholder vote Other customary closing conditions Until the closing of this transaction, Endo and Auxilium will continue to operate as independent companies While integ
Slide 14: Questions?
QUESTIONS?
Slide 15: Endo: improving lives, creating value
@ endo improving lives, creating value.
Auxilium Pharmaceuticals — Merger or Acquisition (October 2014) on 6ix